Sudden Vision Loss in a Patient with Atrial Fibrillation on Anticoagulation
A 70-year-old man with atrial fibrillation on warfarin (INR 2.5) presents with sudden painless loss of vision in his right eye 2 hours ago. Visual acuity is counting fingers at 1 meter. Anterior segment examination is normal. Intraocular pressure is 14 mmHg. Fundus examination reveals a pale, milky-white retina with a cherry-red spot at the macula and a small embolus visible in the superior temporal arteriole. He also has a history of hypertension and hyperlipidemia. He is unsure about the exact time of onset. He asks about treatment options and the likelihood of recovering vision.
1. What is the diagnosis, and what is the pathophysiology and typical timeline for intervention?
Read the worked answer
Diagnosis: Central retinal artery occlusion (CRAO) in the right eye. Pathophysiology: Embolism (likely from the heart due to atrial fibrillation) lodges in the central retinal artery, causing ischemia of the inner retina. The cherry-red spot is due to preserved choroidal circulation at the fovea, contrasting with the opaque, infarcted surrounding retina. Timeline: Irreversible damage occurs after approximately 90–120 minutes of ischemia. However, there is a window of up to 4–6 hours in some cases where intervention might salvage some vision, but outcomes are generally poor. The patient's presentation at 2 hours offers a narrow opportunity for intervention.
2. What immediate and systemic management would you initiate, and what is the prognosis?
Read the worked answer
Immediate management: (1) Ocular massage to dislodge the embolus (though evidence is limited). (2) Anterior chamber paracentesis to lower IOP and potentially increase perfusion. (3) Topical IOP-lowering medications (e.g., timolol, dorzolamide) and systemic acetazolamide to reduce IOP. (4) Inhalation of carbogen (95% O2, 5% CO2) to induce vasodilation (controversial). (5) Systemic evaluation for source of embolus: carotid ultrasound, echocardiogram, and cardiac monitoring. (6) Immediate referral to stroke center because CRAO is a marker of increased stroke risk; consider thrombolysis within 4.5 hours if no contraindications (though not standard for CRAO, recent studies suggest benefit). (7) Optimize anticoagulation with cardiology. Prognosis: Visual recovery is poor; most patients have permanent severe visual loss. About 20% may improve to 20/200 or better. The main goal is to prevent future strokes and cardiovascular events.